Addus Homecare (NASDAQ:ADUS) posted its quarterly earnings results on Monday. The company reported $0.47 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.47, Morningstar.com reports. Addus Homecare had a net margin of 3.20% and a return on equity of 8.95%. The firm had revenue of $149.69 million for the quarter, compared to the consensus estimate of $146.66 million.
Shares of NASDAQ ADUS traded up $3.54 during midday trading on Tuesday, reaching $80.25. 9,333 shares of the company traded hands, compared to its average volume of 90,295. The firm has a market capitalization of $1.05 billion, a price-to-earnings ratio of 47.45, a PEG ratio of 2.44 and a beta of -0.10. The business’s 50-day moving average price is $77.01. Addus Homecare has a 12 month low of $56.75 and a 12 month high of $83.13. The company has a current ratio of 2.87, a quick ratio of 2.87 and a debt-to-equity ratio of 0.10.
ADUS has been the topic of a number of recent research reports. Zacks Investment Research upgraded shares of Addus Homecare from a “hold” rating to a “strong-buy” rating and set a $79.00 price target on the stock in a research note on Monday, May 13th. BidaskClub upgraded shares of Addus Homecare from a “hold” rating to a “buy” rating in a research note on Saturday, July 27th. BMO Capital Markets started coverage on shares of Addus Homecare in a research note on Thursday, June 27th. They set a “market perform” rating on the stock. Sidoti lifted their price objective on Addus Homecare from $84.00 to $96.00 and gave the company a “buy” rating in a report on Tuesday. Finally, Raymond James lifted their price objective on Addus Homecare from $75.00 to $81.00 and gave the company an “outperform” rating in a report on Thursday, June 13th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $79.89.
Large investors have recently made changes to their positions in the business. OppenheimerFunds Inc. grew its position in shares of Addus Homecare by 2.5% in the 1st quarter. OppenheimerFunds Inc. now owns 234,648 shares of the company’s stock valued at $14,921,000 after purchasing an additional 5,820 shares during the period. Jane Street Group LLC boosted its position in Addus Homecare by 12.1% during the 4th quarter. Jane Street Group LLC now owns 4,014 shares of the company’s stock worth $272,000 after acquiring an additional 434 shares during the last quarter. WCM Investment Management LLC boosted its position in Addus Homecare by 69.6% during the 1st quarter. WCM Investment Management LLC now owns 138,459 shares of the company’s stock worth $8,805,000 after acquiring an additional 56,830 shares during the last quarter. Metropolitan Life Insurance Co. NY boosted its position in Addus Homecare by 400.0% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 3,235 shares of the company’s stock worth $220,000 after acquiring an additional 2,588 shares during the last quarter. Finally, TimesSquare Capital Management LLC raised its stake in shares of Addus Homecare by 17.0% during the 1st quarter. TimesSquare Capital Management LLC now owns 882,730 shares of the company’s stock worth $56,133,000 after purchasing an additional 128,330 shares in the last quarter. 98.75% of the stock is owned by hedge funds and other institutional investors.
About Addus Homecare
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Further Reading: How a Put Option Works
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.